|
Market Closed -
Nasdaq
00:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.17 USD | +7.32% |
|
+16.02% | +222.81% |
| 09-25 | SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer | CI |
| 09-14 | Top Premarket Decliners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +7.32% | +16.02% | +4.82% | +7.51% | +222.81% | +511.56% | +1,222.83% | +41.02% | - | 2.29B | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +7.26% | -7.38% | -2.69% | +9.21% | +11.51% | +77.95% | +218.47% | +5,613.87% | 54.57B | |
| +0.16% | +3.69% | +11.70% | +16.02% | +18.22% | +8.39% | +101.27% | -15.72% | +260.84% | 53.59B | |
| -0.75% | +2.13% | +0.44% | +30.52% | +20.47% | +23.14% | +47.25% | +6.04% | +271.38% | 45.03B | |
| -1.30% | -1.11% | +1.44% | +12.32% | +20.49% | +17.77% | +120.71% | -4.58% | +1,012.29% | 42.17B | |
| +1.26% | +2.23% | -9.15% | -1.59% | +133.80% | +241.81% | +835.31% | +586.40% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +17.90% | +31.62% | +59.54% | +47.85% | +56.87% | +47.78% | +1.77% | +171.47% | 26.5B | |
| +0.23% | -2.41% | -11.63% | -2.54% | -8.55% | -17.60% | -9.91% | -70.22% | - | 21.82B | |
| +1.75% | -0.35% | -19.41% | -11.19% | -45.44% | -40.52% | +271.66% | +253.54% | +578.29% | 20.38B | |
| -0.44% | +8.74% | +8.87% | +12.04% | +19.97% | +11.33% | +163.32% | +216.30% | +2,170.95% | 18.93B | |
| +0.44% | +19.61% | +22.54% | +58.37% | +79.89% | +82.12% | +104.97% | -16.52% | +360.11% | 17.06B | |
| -0.58% | +8.28% | +10.50% | +28.73% | +36.99% | +35.86% | +86.88% | -16.65% | +108.95% | 16.69B | |
| +0.37% | +4.26% | +12.36% | +18.02% | +49.10% | +68.78% | +211.34% | +201.71% | +484.53% | 16.13B | |
| +0.29% | +6.91% | +8.98% | -3.16% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.44% | +8.83% | +6.18% | +10.39% | +0.42% | +2.73% | -23.94% | -35.83% | +124.74% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | +0.01% | +4.29% | +2.48% | +12.95% | +47.85% | +65.99% | +224.10% | +151.10% | +930.12% | 27.81B | |
| Weighted average by Cap. | -0.48% | +2.94% | +0.52% | +13.03% | +37.46% | +42.73% | +162.06% | +121.54% | +1,252.34% |
- Stock Market
- Stocks
- SLS Stock
- Sector SELLAS Life Sciences Group, Inc.
Select your edition
All financial news and data tailored to specific country editions
